Anika to Participate in the Sidoti Virtual Investor Conference
Rhea-AI Summary
Anika Therapeutics (NASDAQ: ANIK), a global joint preservation company specializing in early intervention orthopedics, has announced its participation in the upcoming Sidoti Virtual Investor Conference. The event is scheduled for Thursday, August 15, 2024, with Anika's management team set to deliver a virtual presentation followed by a Q&A session starting at 11:30 AM ET.
Investors and interested parties can access the live webcast of the presentation and Q&A through the Investor Relations section of Anika's website at www.anika.com. For those unable to attend the live event, an archived version of the presentation will be made available on the company's website for future reference.
Positive
- None.
Negative
- None.
BEDFORD, Mass., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will participate in the Sidoti Virtual Investor Conference on Thursday, August 15, 2024. Anika will host a virtual presentation with Q&A starting at 11:30am ET.
Webcast of the presentation and Q&A will be available in the Investor Relations section of Anika’s website, www.anika.com. An archive of the presentation will also be available on the website.
About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.
ANIKA, ANIKA THERAPEUTICS and the Anika logo are registered trademarks of Anika Therapeutics, Inc.
For Investor Inquiries:
Anika Therapeutics, Inc.
Mark Namaroff, 781-457-9287
Vice President, Investor Relations, ESG and Corporate Communications
investorrelations@anika.com
FAQ
When is Anika Therapeutics (ANIK) participating in the Sidoti Virtual Investor Conference?
What time is Anika's (ANIK) presentation at the Sidoti Virtual Investor Conference?
How can investors access Anika's (ANIK) presentation at the Sidoti Virtual Investor Conference?
Will there be a Q&A session during Anika's (ANIK) presentation at the Sidoti conference?
Can I watch a replay of Anika's (ANIK) presentation from the Sidoti Virtual Investor Conference?
